These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity. Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA. J Clin Endocrinol Metab; 1995 Dec; 80(12):3576-81. PubMed ID: 8530601 [Abstract] [Full Text] [Related]
29. Urinary excretion of cyclic nucleotides and phosphate in response to parathyroid hormone and calcitonin in man. Suh SM, Firek AF, Kim DH, Ramanathan S. Pediatr Res; 1981 Oct; 15(10):1359-62. PubMed ID: 6272182 [Abstract] [Full Text] [Related]
30. Urinary cyclic AMP. Relation to albumin-corrected serum calcium in healthy persons and patients with primary hyperparathyroidism. Madsen SN, Badawi I, Jorgensen FS, Skovsted L, Transbol I. Acta Med Scand; 1976 Oct; 200(3):195-9. PubMed ID: 184691 [Abstract] [Full Text] [Related]
34. Effects of antibody to renal plasma membrane on urinary excretion of adenosine 3',5'-monophosphate and phosphate induced by parathyroid hormone infusion in rats. Yamada K, Saito Y, Tamura Y, Yamamoto M, Kumagai A. Endocrinology; 1980 Mar; 106(3):973-8. PubMed ID: 6243559 [Abstract] [Full Text] [Related]
35. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism. Neer RM, Tregear GW, Potts JT. J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258 [Abstract] [Full Text] [Related]
36. Calcitonin stimulation of cyclic adenosine 3':5'-monophosphate production with growth inhibition in human renal adenocarcinoma cell lines. Kinoshita Y, Fukase M, Takenaka M, Nakada M, Miyauchi A, Fujita T. Cancer Res; 1985 Oct; 45(10):4890-4. PubMed ID: 2992768 [Abstract] [Full Text] [Related]
38. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
39. Impaired parathyroid hormone action on urinary phosphorus excretion in isolated perfused kidney of streptozotocin-induced diabetic rats. Mokuda O, Sakamoto Y. Horm Metab Res; 1999 Oct; 31(10):543-5. PubMed ID: 10596962 [Abstract] [Full Text] [Related]
40. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses. Law WM, Heath H. J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]